AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
2
Israeli startup Thermagix claims “the only economical solution for harvesting low-grade heat”
3
Oasis Security raises $120 million Series B to secure the rise of AI agents
4
Israel orders airborne laser system for fighter jets and helicopters
5
After Symantec exit, Javelin founders raise $20 million for new cyber bet Raven
More news

PhaseV

4 stories about PhaseV
Promising HealthTech

WATCH: CTech's most promising healthtech startups

29.05.25|CTech
Here's everything you need to know about Sensi.ai, Briya Labs, PhaseV, Zorro, and DeepCure
כנס ניו יורק - ד"ר רביב פרילוק מנכ"ל PhaseV

PhaseV raises $50 million Series A to rethink how drugs get to market

13.05.25|CTech
With over 30 global customers, the AI startup targets inefficiencies in clinical trials. 
CTech NY Conference Dr Raviv Pryluk

Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development

27.03.25|James Spiro
CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalist’s Mind The Tech conference in New York. 
Raviv Pryluk PhaseV

PhaseV raises $15 million to optimize clinical trials with causal machine learning

24.10.23|CTech
The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps